Výsledky vyhledávání - "Simon Nitschky Schmidt"

Akademický článek

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.

Autor: Steven G Potkin, Jean-Yves Loze, Carlos Forray, Ross A Baker, Christophe Sapin, Timothy Peters-Strickland, Maud Beillat, Anna-Greta Nylander, Peter Hertel, Simon Nitschky Schmidt, Anders Ettrup, Anna Eramo, Karina Hansen, Dieter Naber

Publikováno v: PLoS ONE, Vol 12, Iss 8, p e0183475 (2017)

Schizophrenia is a chronic disease with negative impact on patients' employment status and quality of life. This post-hoc analysis uses data from the QUALIFY study to elucidate the relationship between work readiness and health-related quality of lif

Externí odkaz: https://doaj.org/article/b5d30494aa3d4448b36c28ade08cdac6

Zobrazit plný text záznamu

Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies

Autor: Gregory W. Mattingly, Oscar Necking, Simon Nitschky Schmidt, Elin Reines, Hongye Ren

Publikováno v: Current Medical Research and Opinion. 39:613-619

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa5a272d477617fa237d57af754b37db
https://doi.org/10.1080/03007995.2023.2178082

Zobrazit plný text záznamu

Efficacy and safety of vortioxetine in treatment of patients with major depressive disorder and common co-morbid physical illness

Autor: David S, Baldwin, Oscar, Necking, Simon Nitschky, Schmidt, Hongye, Ren, Elin H, Reines

Publikováno v: Journal of Affective Disorders. 311:588-594

The multimodal antidepressant vortioxetine is effective in reducing somatic symptoms in patients with major depressive disorder (MDD), but little is known about its effects in reducing depressive symptoms in patients with common comorbid physical ill

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2b11cd54c76d4b015d2848a85c72610
https://doi.org/10.1016/j.jad.2022.05.098

Zobrazit plný text záznamu

Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate

Autor: Carlos Forray, Ross A. Baker, Dieter Naber, Anna-Greta Nylander, Steven G. Potkin, Timothy Peters-Strickland, M. Beillat, Simon Nitschky Schmidt, Christophe Sapin, Peter Hertel, Anna Eramo, K. Hansen, Jean-Yves Loze

Publikováno v: International Journal of Neuropsychopharmacology
Potkin, SG; Loze, J-Y; Forray, C; Baker, RA; Sapin, C; Peters-Strickland, T; et al.(2017). Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 20(1). doi: 10.1093/ijnp/pyw093. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/6nf259k4

Author(s): Potkin, Steven G; Loze, Jean-Yves; Forray, Carlos; Baker, Ross A; Sapin, Christophe; Peters-Strickland, Timothy; Beillat, Maud; Nylander, Anna-Greta; Hertel, Peter; Nitschky Schmidt, Simon; Eramo, Anna; Hansen, Karina; Naber, Dieter | Abst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e17aad621473e7b16e0a96b473bf7c
http://europepmc.org/articles/PMC5578804

Zobrazit plný text záznamu

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study

Autor: Simon Nitschky Schmidt, Anders Ettrup, Eduard Vieta, Johan Areberg, Ioana Florea

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
International Clinical Psychopharmacology

This 2-week randomized, double-blind, placebo-controlled fixed-dose study (NCT02919501) explored the potential of accelerating onset of antidepressant efficacy and plasma exposure with single-dose intravenous vortioxetine at oral vortioxetine treatme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22d5f66f2dad70cafa48cd49fdda0a8
http://hdl.handle.net/2445/179034

Zobrazit plný text záznamu

Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study

Autor: Anna-Greta Nylander, Steven G. Potkin, Timothy Peters-Strickland, K. Hansen, Jean-Yves Loze, Peter Hertel, Simon Nitschky Schmidt, Dieter Naber, Christophe Sapin, Anna Eramo, Ross A. Baker, Carlos Forray

Publikováno v: Schizophrenia research. 192

Objective To evaluate long-term safety and effectiveness of continued treatment with aripiprazole once-monthly 400 mg (AOM 400) in patients with schizophrenia. Methods Patients who completed the QUALIFY study ( NCT01795547 ) in the AOM 400 arm were e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223a6cd3b9d5cb87898ecb955c54e4f3
https://pubmed.ncbi.nlm.nih.gov/28433498

Zobrazit plný text záznamu

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study

Autor: Carlos Forray, Simon Nitschky Schmidt, Dieter Naber, Anna-Greta Nylander, Anders Ettrup, Christophe Sapin, Anna Eramo, M. Beillat, K. Hansen, Peter Hertel, Ross A. Baker, Steven G. Potkin, Timothy Peters-Strickland, Jean-Yves Loze

Publikováno v: PLoS ONE, Vol 12, Iss 8, p e0183475 (2017)
PLoS ONE

Schizophrenia is a chronic disease with negative impact on patients’ employment status and quality of life. This post-hoc analysis uses data from the QUALIFY study to elucidate the relationship between work readiness and health-related quality of l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a17d3909419d218677cedf49966d3bc
https://doi.org/10.1371/journal.pone.0183475

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání